G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $315,000 | -65.5% | 11,912 | -78.4% | 0.02% | -70.9% |
Q1 2019 | $914,000 | +25.2% | 55,038 | +44.4% | 0.06% | +17.0% |
Q4 2018 | $730,000 | +7.0% | 38,125 | +192.2% | 0.05% | +51.6% |
Q3 2018 | $682,000 | -32.4% | 13,047 | -43.8% | 0.03% | -24.4% |
Q2 2018 | $1,009,000 | +134.1% | 23,232 | +99.5% | 0.04% | +141.2% |
Q1 2018 | $431,000 | – | 11,645 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
Birchview Capital, LP | 40,000 | $217 | 0.15% |
XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |